UnitedHealth Group Inc (NYSE:UNH) Director Richard T. Burke sold 5,000 shares of the stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $245.01, for a total transaction of $1,225,050.00. Following the sale, the director now directly owns 182,372 shares in the company, valued at $44,682,963.72. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Shares of UnitedHealth Group stock opened at $251.40 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market cap of $243.06 billion, a P/E ratio of 19.52, a PEG ratio of 1.26 and a beta of 0.79. UnitedHealth Group Inc has a 12 month low of $212.49 and a 12 month high of $287.94.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share for the quarter, topping the consensus estimate of $3.20 by $0.08. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The business had revenue of $58.42 billion for the quarter, compared to analyst estimates of $58.01 billion. During the same quarter last year, the company earned $2.59 EPS. The business’s quarterly revenue was up 12.2% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Inc will post 14.62 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date of this dividend is Friday, March 8th. UnitedHealth Group’s payout ratio is currently 27.95%.

A number of brokerages have recently issued reports on UNH. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Friday, January 11th. Credit Suisse Group restated a “buy” rating and set a $310.00 target price on shares of UnitedHealth Group in a research note on Friday, February 8th. Argus raised their target price on shares of UnitedHealth Group from $285.00 to $295.00 and gave the stock a “buy” rating in a research note on Monday, December 17th. Stephens began coverage on shares of UnitedHealth Group in a research report on Monday, January 14th. They set an “overweight” rating and a $287.00 price objective on the stock. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $310.00 target price on shares of UnitedHealth Group in a report on Tuesday, January 15th. Two analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $297.80.

Several institutional investors have recently bought and sold shares of UNH. Crewe Advisors LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth $25,000. Pearl River Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $35,000. Ipswich Investment Management Co. Inc. acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $40,000. OLD Second National Bank of Aurora raised its holdings in shares of UnitedHealth Group by 70.0% in the fourth quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock worth $42,000 after acquiring an additional 70 shares during the last quarter. Finally, Laurel Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $42,000. Hedge funds and other institutional investors own 85.80% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was first reported by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.dailypolitical.com/2019/03/17/insider-selling-unitedhealth-group-inc-unh-director-sells-5000-shares-of-stock.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: How prevalent are 12b-1 fees?

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.